ReviewCurrent treatment options in oncology2019
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma.
Chi-Che Hsieh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ReviewCurrent treatment options in oncology2019
Chi-Che Hsieh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.